Indoco Remedies Ltd
INDOCOIndoco Remedies Ltd
INDOCO
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 24.33 | 3.03 | 0.67% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 39.58 | 4.65 | 0.79% |
Forecast & Ratings
Detailed Forecastfrom 6 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Indoco Remedies Limited is engaged in the manufacture of pharmaceutical products. The Company primarily manufactures and markets Formulations (Finished Dosage Forms) and Active Pharmaceutical Ingredients (APIs).
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 858.67 | 1,009.68 | 1,078.73 | 1,046.63 | 974.60 | 1,109.02 | 1,244.65 | 1,543.08 | 1,670.95 | 1,688.52 | ||||||||||
Raw Materials | 319.69 | 361.13 | 362.83 | 344.53 | 306.93 | 338.48 | 366.23 | 483.09 | 514.74 | 1,411.08 | ||||||||||
| Power & Fuel Cost | 20.39 | 21.72 | 23.12 | 26.62 | 28.49 | 34.75 | 36.89 | 42.78 | 50.61 | |||||||||||
| Employee Cost | 140.04 | 181.87 | 216.67 | 220.91 | 231.66 | 256.51 | 274.02 | 296.28 | 322.58 | |||||||||||
| Selling & Administrative Expenses | 173.29 | 216.81 | 255.89 | 246.31 | 241.21 | 287.26 | 257.82 | 292.67 | 339.43 | |||||||||||
| Operating & Other expenses | 38.03 | 56.18 | 59.79 | 68.64 | 83.51 | 66.38 | 82.30 | 98.59 | 155.15 | |||||||||||
EBITDA | 167.23 | 171.97 | 160.43 | 139.62 | 82.80 | 125.64 | 227.39 | 329.67 | 288.44 | 277.44 | ||||||||||
| Depreciation/Amortization | 47.09 | 60.66 | 63.28 | 67.71 | 71.57 | 70.82 | 73.13 | 78.96 | 70.61 | 70.39 | ||||||||||
| PBIT | 120.14 | 111.31 | 97.15 | 71.91 | 11.23 | 54.82 | 154.26 | 250.71 | 217.83 | 207.05 | ||||||||||
| Interest & Other Items | 10.58 | 12.39 | 6.21 | 23.51 | 20.54 | 26.25 | 22.26 | 14.14 | 25.03 | 28.69 | ||||||||||
| PBT | 109.56 | 98.92 | 90.94 | 48.40 | -9.31 | 28.57 | 132.00 | 236.57 | 192.80 | 178.36 | ||||||||||
| Taxes & Other Items | 26.74 | 16.99 | 13.87 | 7.23 | -6.41 | 4.46 | 38.95 | 81.77 | 50.55 | 50.29 | ||||||||||
| Net Income | 82.82 | 81.93 | 77.07 | 41.17 | -2.90 | 24.11 | 93.05 | 154.80 | 142.25 | 128.07 | ||||||||||
| EPS | 8.99 | 8.89 | 8.36 | 4.47 | -0.31 | 2.62 | 10.10 | 16.80 | 15.44 | 13.90 | ||||||||||
| DPS | 1.60 | 1.60 | 1.60 | 1.00 | 0.30 | 0.30 | 1.50 | 2.25 | 2.25 | 2.25 | ||||||||||
| Payout ratio | 0.18 | 0.18 | 0.19 | 0.22 | — | 0.11 | 0.15 | 0.13 | 0.15 | 0.16 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Indoco Remedies Ltd | 21.90 | 3.03 | 0.67% |
| Sun Pharmaceutical Industries Ltd | 31.83 | 4.55 | 1.02% |
| Cipla Ltd | 33.98 | 4.02 | 0.72% |
| Dr Reddy's Laboratories Ltd | 20.08 | 3.89 | 0.74% |
Price Comparison
Compare INDOCO with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Sep 2022
Dec 2022
Mar 2023
Jun 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding Indoco Remedies Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
Nippon India SMALL CAP FUND DIRECT PLAN GROWTH PLAN GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 2.7787% | Percentage of the fund’s portfolio invested in the stock 0.24% | Change in the portfolio weight of the stock over the last 3 months -0.04% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 87/204 (-5) |
ICICI Prudential Smallcap Fund - Growth - Direct Plan Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.9862% | Percentage of the fund’s portfolio invested in the stock 0.96% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 47/68 (-2) |
Nippon India PHARMA FUND DIRECT PLAN GROWTH PLAN - GROWTH OPTION GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 1.8577% | Percentage of the fund’s portfolio invested in the stock 1.05% | Change in the portfolio weight of the stock over the last 3 months -0.16% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 25/33 (0) |
Compare 3-month MF holding change on Screener
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividend Cuts
INDOCO has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.66%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.62 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateSep 18, 2023
Dividend/Share
₹2.25
Ex DateEx Date
Sep 18, 2023
Cash Dividend
Ex DateEx DateSep 14, 2022
Dividend/Share
₹1.50
Ex DateEx Date
Sep 14, 2022
Cash Dividend
Ex DateEx DateSep 14, 2022
Dividend/Share
₹0.75
Ex DateEx Date
Sep 14, 2022
Cash Dividend
Ex DateEx DateSep 17, 2021
Dividend/Share
₹1.50
Ex DateEx Date
Sep 17, 2021
Cash Dividend
Ex DateEx DateSep 18, 2020
Dividend/Share
₹0.30
Ex DateEx Date
Sep 18, 2020
News & Opinions
Indoco Remedies - Resolution Of Facilities A Key Monitorable: Nirmal Bang
2 weeks ago•Bloomberg Quint
Buy Indoco Remedies; target of Rs 380: Prabhudas Lilladher
2 months ago•Moneycontrol
Indoco Remedies shares rise following EU GMP certification
2 months ago•The Hindu Businessline
Indoco Remedies Q1 PAT may dip 0.1% YoY to Rs 38.5 cr: Nirmal Bang
2 months ago•Moneycontrol
Stocks to watch on June 12, 2023
3 months ago•The Hindu Businessline
Indoco Remedies gets EU-GMP certification for Himachal plant
3 months ago•Economic Times
Indoco Remedies gains on board nod to buy 85% in US generics marketer
3 months ago•Moneycontrol
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 9.81%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.52% to 0.53%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 28.14%, vs industry avg of 9.82%